Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

Lignende værker

• Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
  af: Ordoñez-Boschetti, Laura, et al.
  Udgivet: (2015)
• Use of Fingolimod in the Management of Relapsing–Remitting Multiple Sclerosis: Experience from Latin America
  af: Correale, Jorge, et al.
  Udgivet: (2015)
• Erratum to: Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group
  af: Fazekas, Franz
  Udgivet: (2013)
• Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
  af: Doosti, Rozita, et al.
  Udgivet: (2021)
• Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
  af: Kuhle, Jens, et al.
  Udgivet: (2015)